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Received December 30, 2011; accepted March 30, 2012AbstractBackground: Metaplastic carcinoma of the breast (MPCB) is a rare breast cancer. We reviewed sonographic findings for MPCB.
Methods: Grayscale ultrasonography (US), color Doppler US (CDUS), and spectral Doppler US (SDUS) findings for 10 patients with MPCB
breast were retrospectively reviewed.
Results: The prevalence of MPCB was 3.9% among cases of breast cancer in our hospital. All patients had a rapidly growing palpable breast
mass. The mean lesion size was 5.7 cm. On US, the lesion shape was most commonly gently lobulated (90%); only one showed an irregular
shape (10%). The lesion shape was most commonly circumscribed (90%). Nine tumors had an abrupt boundary and one had an indistinct
boundary. Lesion echogenicity was hypoechoic and very hypoechoic (40%), hypoechoic (30%), or very hypoechoic, hypoechoic, and hyper-
echoic (30%). All our cases had cystic parts with posterior acoustic enhancement, representing necrosis or hemorrhage. CDUS showed
peripheral, central and marginal color flow signals. The resistivity index (RI) of tumor vessels in the lesions ranged from 0.7 to 1.3. The axillary
lymph nodes were enlarged on US and were positive for metastasis in three cases (30%).
Conclusion: MPCB is a rare rapidly growing tumor. US findings included gently lobulated, complex mass lesion with cystic parts and posterior
acoustic enhancement, representing necrosis or hemorrhage. Increased color flow signals and relative high RI of the feeding arteries were also
seen.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Metaplastic carcinoma of the breast (MPCB) is a very rare
breast cancer, accounting for less than 1e5% of all breast
cancers.1e3 It encompasses purely epithelial carcinoma and
mixed epithelial and mesenchymal carcinoma.4 The objective
of this study was to retrospectively review ultrasonographic
(US) findings for MPCB, including grayscale US, color* Corresponding author: Dr. Chui-Mei Tiu, Department of Radiology, Taipei
Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan,
ROC.
E-mail address: cmtiu@vghtpe.gov.tw (C.-M. Tiu).
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http://dx.doi.org/10.1016/j.jcma.2012.08.005Doppler US (CDUS), and spectral Doppler US (SDUS), over
a period of 10 years.
2. Methods
A total of 10 pathologically proven MPCB cases were
encountered from 2002 to 2011 in Taipei Veterans General
Hospital. Preoperative US studies of the breasts and axillae
were performed in 10 patients. US was performed using high-
resolution linear transducers. The sonograms were analyzed
retrospectively by three experienced radiologists. The MPCB
shape and margin were described according to the American
College of Radiology Breast Imaging Reporting and Datahinese Medical Association. All rights reserved.
Table 1
Clinical information and pathological findings for ten patients.
Case Age
(y)
Location Chief complaint and
physical findings
Treatment Stage Subtype ER/PR/HER2 Outcome
1 81 Left Palpable mass for 2 y,
recently enlarged
MRM T3N1M1 Adenocarcinoma
with SCM
// Local recurrence and
lung metastasis; expired
2 68 Right Large palpable mass for 2 y,
recently enlarged
MRM T2N1M1 Adenocarcinoma
with SCM
// Pleural, lung and liver
metastasis; expired
3 44 Right Palpable mass for 1 mo BCS, adjuvant C/T T2N0M0 Carcinoma with CD // No recurrence
4 84 Right Painful mass for 1 mo BCS T1N0M0 Carcinoma and OD þ//NA No recurrence
5 38 Right Palpable mass for 6 d MRM T1N0M0 Adenosquamous
carcinoma
//þ No recurrence
6 46 Left Large palpable mass for 1 y,
recently enlarged
MRM, adjuvant C/T T3N0M0 Adenocarcinoma
with SCM
//þ No recurrence
7 50 Left Palpable mass for 1 mo MRM and C/T T2N0M0 Adenosquamous
carcinoma
//þ No recurrence
8 57 Left Large palpable mass for 1 y MRM and C/T T4N1M0 Carcinoma with CD // No recurrence
9 45 Right Large palpable mass for 1 y BCS, adjuvant C/T T3N0M0 Carcinoma with CD // No recurrence
10 36 Right Painful mass for 3 wks MRM T2N0Mx Adenocarcinoma
with SCM
// No recurrence
BCS ¼ breast-conserving surgery; CD ¼ chondroid differentiation; C/T ¼ chemotherapy; ER ¼ estrogen receptor; HER2 ¼ human epidermal growth factor
receptor 2; MRM ¼ mastectomy; NA ¼ not available; OD ¼ osseous differentiation; PR ¼ progesterone receptor; SCM ¼ spindle cell metaplasia.
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The MPCB echogenicity was classified as cystic, very hypo-
ehoic, hypoechoic, or hyperechoic. When a lesion showed
echogenicity minimally less than that of subcutaneous fat, it
was defined as hypoechoic. If the echogenicity of a lesion was
very weak and much less than that of subcutaneous fat, the
lesion was defined as very hypoechoic.
Histopathological studies were reviewed by one breast
pathologist (C.-Y.H.). The subtype, chondroid matrix, cystic
part, calcification, and hormone receptors for the lesions and
the lymph node status were also reviewed and documented.
3. Results
From 2002 to 2011, the total number of breast malignancies
was 3962 according to the cancer registration system in Taipei
Veterans General Hospital. Among these, 10 cases were
MPCB. The MPCB prevalence was therefore 3.9%. Table 1
lists clinical information and pathological findings for the 10
patients. All patients presented with a palpable breast mass.Table 2
Sonographic findings for metaplastic carcinoma.
Case Size (cm) Shape Grayscale
Echogenicity Cystic par
1 3.1  2.7 Gently lobulated Mixed pattern Peripheral
2 3.5  2.8 Irregular Very HE and HE Peripheral
3 3.5  3.8 Gently lobulated Very HE and HE Central
4 1.4  1 Gently lobulated Very HE and HE Central
5 4.1  3.4 Gently lobulated HE Peripheral
6 11.5  7 Gently lobulated Mixed pattern Peripheral
7 3  2.8 Gently lobulated Very HE and HE Peripheral
8 15  10 Gently lobulated Mixed pattern Peripheral
9 5.6  4.8 Gently lobulated HE Peripheral
10 6.3  3.6 Gently lobulated HE Peripheral
Cal ¼ calcification; HE ¼ hypoechoic; Mixed pattern ¼ mixed hypo-, iso-, and h
index.The duration between observation of a palpable mass by the
patient and medical consultation varied from 6 days to 2 years.
One patient had previous contralateral breast cancer and
underwent total mastectomy 19 years before. The average
patient age was 55 years (range 36e81). The mean longest
dimension of the lesions was 5.7 cm (range 1e15).
Table 2 lists US findings for the 10 lesions. The echoge-
nicity of the lesions was hypoechoic and very hypoechoic (4/
10), hypoechoic (3/10), or very hypoechoic, hypoechoic and
hyperechoic (3/10) (Figs. 1e5). The lesion shape was gently
lobulated (9/10) or irregular (1/10) (Figs. 1, 2, and 4). All our
cases had cystic areas with posterior enhancement. The cystic
areas were either central (2/10) or peripheral (3/10), and five
patients had both central and peripheral cystic areas. Calcifi-
cations were found in four patients (4/10). In lesions with
measurable calcification, the size range was 0.4e1.2 mm
(0.7  0.3 mm). Only one lesion presented with large calcific
areas that were actually ossifications. CDUS was performed
on all lesions, and SDUS was performed for eight patients.
Seven lesions showed central, peripheral, and marginal colorultrasound Doppler ultrasound
t PE Cal Color flow signals RI
þ þ Peripheral 0.88
, central þ  Marginal, peripheral, central 1-1.3
þ  Marginal, peripheral, central 0.75
þ þ (coarse) Peripheral 1
þ þ Peripheral, central 0.75
þ  Marginal, peripheral, central N/A
, central þ  Marginal, peripheral, central 1
, central þ þ Marginal, peripheral, central NA
, central þ  Marginal, peripheral, central 0.77
, central þ  Marginal, peripheral, central 0.72
yperechoic; NA ¼ not available; PE ¼ posterior enhancement; RI ¼ resistive
Fig. 1. Case 1. Adenocarcinoma and spindle cell metaplasia. (A) Grayscale ultrasound (US) reveals a heterogeneously hypoechoic mass with a gently lobulated and
angular margin (large arrows). The lesion is associated with small cystic necrotic areas (small arrows) and posterior enhancement (arrowheads). (B) Color Doppler
US shows increased color flow signals (arrowheads) in the mass. (C) Spectral Doppler US shows a high resistive index (1.0; arrowhead) in the feeding artery.
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color flow signals (20%). The average RI of the lesions was
0.88 (range 0.7e1.3) (Figs. 1e3).
Seven patients underwent total mastectomy and three
patients received breast-conserving surgery. All patients
underwent axillary lymph node dissection. Lymph node
involvement was positive in three cases. Five patients received
adjuvant or neoadjuvant chemotherapy.
Microscopy studies were reviewed and the specific meta-
plastic components were identified. Table 1 outlines the
pathology findings. The subtypes included purely epithelial
carcinoma in six cases (adenoaquamous carcinoma in two, and
adenocarcinoma with spindle cell metaplasia in four) and
mixed epithelial and mesenchymal carcinoma in four (carci-
noma with chondroid differentiation in three, and carcinoma
with osseous differentiation in one). Enlarged axillary lymph
nodes demonstrated on US were histologically confirmed as
metastasis in three patients.
Estrogen receptor (ER) and progesterone receptor (PR)
status was reviewed for all patients. Only one lesion was ER-positive. All lesions were PR-negative. Human epidermal
growth factor receptor 2 (HER2) status was reviewed in nine
patients. Three were positive.
Eight patients were disease-free until 2011. One patient
developed local recurrence 18 months after surgery and died
of lung metastasis. The other expired due to lung and liver
metastasis 18 months after surgery.
4. Discussion
MPCB is the rarest breast malignancy of ductal origin.
According to the cancer register in our hospital, the prevalence
is 3.9% among breast malignancies. This is close to the
average incidence reported in the literature.1e3 MPCB is
divided into two groups: (1) purely epithelial carcinoma,
including squamous carcinoma, adenoaquamous carcinoma,
and adenocarcinoma with spindle cell metaplasia; and (2)
mixed epithelial and mesenchymal carcinoma, including
carcinoma with chondroid differentiation, carcinoma with
osseous differentiation, and carinosarcoma.4
Fig. 2. Case 2. Adenocarcinoma and spindle cell metaplasia. (A) Grayscale ultrasound (US) reveals a heterogeneously hypoechoic mass with an irregular shape
(large arrows), small cystic areas (small arrows), and posterior enhancement (arrowheads). (B) Color Doppler US shows increased color flow signals (arrowheads)
in the mass. (C) Histopathological examination reveals many small vessels (arrowheads; hematoxylin and eosin stain, 200). (D) Spectral Doppler US shows
a very high resistive index (1.3; arrowheads) in the feeding artery.
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was negative in nine of our patients, and PR was negative in all
our patients. Three of the tumors were positive for HER2.
Cystic areas found in MPCB can be a result of necrosis or
hemorrhage.5e8 All of our cases showed the presence of cystic
areas that correlated with pathological findings for necrosis or
hemorrhage. When in areas without fluid spaces, the tumors
showed hypercellularity on histological examination, which
contributed to their the relative hypoechogenicity and poste-
rior acoustic enhancement.9 Posterior acoustic enhancement
was found in all lesions in our series, possibly due to cystic
areas and/or hypercellularity.
The microcalcification pattern can be used as a criterion to
differentiate ductal carcinoma in situ (DCIS) and MPCB.
Usually, US-detectable microcalcifications in DCIS are
smaller (w0.1 mm),10 while calcifications in MPCB are larger
(w0.7 mm). In addition, other echo features differ between
MPCB and DCIS. Grayscale US findings for MPCB include
a gently lobulated complex mass with cystic areas and
posterior acoustic enhancement, while DCIS usually shows
a poorly defined margin and an intermediate posterior acoustic
phenomenon.One of the 10 tumors contained ossifications. The patholog-
ical subtype of this case was carcinoma with osseous differen-
tiation. Care is needed to avoidmistaking thisMPCB subtype for
calcified fibroadenoma on US. The relatively rapid growth,
cystic areas, and hypervascularity of this MPCB subtype may be
helpful in differentiating it from calcified fibroadenoma,which is
slow-growing and has little or almost no vascularity.11
RI values reported for benign tumors were 0.6  0.11,12
0.62  0.095,13 and 0.62,14 and values for malignant tumors
were 0.75  0.07,12 0.74  0.097,13 and 0.7.14 Although there
is some controversy,11 the RI of malignant tumors is consid-
ered to be significantly higher than that of benign tumors.
SDUS was performed on eight lesions in our study. The
average RI was 0.88, which is higher than values reported for
benign tumors and for breast cancers (not otherwise spec-
ified).The high RI may be due to high tumor stiffness.
Three of our patients presented with positive axillary lymph
nodes. This incidence is similar to that in other studies
(w12.5e40%).5,7,15,16 Distant metastasis may occur without
positive axillary node metastasis.16e18 Hematogenous metas-
tasis is more frequent than lymphangitic spreading.7,17e19 Two
of our patients developed distant metastasis, including lung
Fig. 3. Case 3. Carcinoma and chondroid differentiation. (A) Grayscale ultrasound (US) reveals a heterogeneously hypoechoic mass with a gently lobulated shape
(large arrows), a cystic necrotic area (small arrows), and posterior enhancement (arrowheads). (B) Color Doppler US shows increased color flow signals
(arrowheads) in the mass. (C) Histopathological examination demonstrates large chondromyxoid areas (stars) corresponding to cystic necrosis on US (hematoxylin
and eosin stain, 100). The peripheral part of the tumor shows vascular proliferation (arrowheads). (D) Spectral Doppler US shows a high resistive index (0.8;
arrowheads) in the feeding artery.
Fig. 4. Case 4. Carcinoma and osseous differentiation. (A) Grayscale ultrasound (US) reveals a heterogeneously hypoechoic mass with a gently lobulated shape
(large arrows) and coarse calcification (small arrows). (B) Histopathological examination also shows calcified zones (arrowheads; hematoxylin and eosin stain,
100).
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Fig. 5. Case 5. Adenosquamous carcinoma. (A) Grayscale ultrasound (US)
reveals a heterogeneously hypoechoic mass with a gently lobulated shape
(large arrows) and cystic areas (small arrows). Several small hyperechoic foci
(arrowheads) are present in the lesion, representing small calcifications
(0.7e1.0 mm). (B) Spectral Doppler US shows a high resistive index (0.75;
arrowheads) in the feeding artery.
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distant metastasis occurred. The two patients with distant
metastasis both expired. Local recurrence and distant metas-
tasis indicate very poor prognosis.
In conclusion, MPCB is a rare breast malignancy. US
findings for MPCB include a gently lobulated complex mass
with a cystic area and posterior acoustic enhancement. Coarsecalcifications may be found in the subtype carcinoma with
osseous differentiation. On CDUS and SDUS, hyper-
vascularity and high RI are frequently seen. Although these
US features are not pathognomonic in the diagnosis of MPCB,
this unusual entity should be included in the differential
diagnoses when a relatively large breast tumor with the above-
mentioned US manifestations is encountered.
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